
### [MONDO:0019662](http://purl.obolibrary.org/obo/MONDO_0019662)
**Label:** short rib-polydactyly syndrome, Majewski type

**Subclasses:** [MONDO:0009894](http://purl.obolibrary.org/obo/MONDO_0009894) (short-rib thoracic dysplasia 6 with or without polydactyly), [MONDO:0013127](http://purl.obolibrary.org/obo/MONDO_0013127) (asphyxiating thoracic dystrophy 3), 

**Mapped go classes:** [GO:0035264](http://purl.obolibrary.org/obo/GO_0035264) (multicellular organism growth), [GO:0030030](http://purl.obolibrary.org/obo/GO_0030030) (cell projection organization), [GO:0006468](http://purl.obolibrary.org/obo/GO_0006468) (protein phosphorylation), [GO:0023014](http://purl.obolibrary.org/obo/GO_0023014) (signal transduction by protein phosphorylation), [GO:0051301](http://purl.obolibrary.org/obo/GO_0051301) (cell division), [GO:0000166](http://purl.obolibrary.org/obo/GO_0000166) (nucleotide binding), [GO:0005524](http://purl.obolibrary.org/obo/GO_0005524) (ATP binding), [GO:0000242](http://purl.obolibrary.org/obo/GO_0000242) (pericentriolar material), [GO:0004713](http://purl.obolibrary.org/obo/GO_0004713) (protein tyrosine kinase activity), [GO:0001822](http://purl.obolibrary.org/obo/GO_0001822) (kidney development), [GO:0032147](http://purl.obolibrary.org/obo/GO_0032147) (activation of protein kinase activity), [GO:0016310](http://purl.obolibrary.org/obo/GO_0016310) (phosphorylation), [GO:0010212](http://purl.obolibrary.org/obo/GO_0010212) (response to ionizing radiation), [GO:0042769](http://purl.obolibrary.org/obo/GO_0042769) (DNA damage response, detection of DNA damage), [GO:0060271](http://purl.obolibrary.org/obo/GO_0060271) (cilium assembly), [GO:0031098](http://purl.obolibrary.org/obo/GO_0031098) (stress-activated protein kinase signaling cascade), [GO:0007283](http://purl.obolibrary.org/obo/GO_0007283) (spermatogenesis), [GO:1904888](http://purl.obolibrary.org/obo/GO_1904888) (cranial skeletal system development), [GO:0004672](http://purl.obolibrary.org/obo/GO_0004672) (protein kinase activity), [GO:0042981](http://purl.obolibrary.org/obo/GO_0042981) (regulation of apoptotic process), [GO:0006974](http://purl.obolibrary.org/obo/GO_0006974) (cellular response to DNA damage stimulus), [GO:0004674](http://purl.obolibrary.org/obo/GO_0004674) (protein serine/threonine kinase activity), [GO:0007049](http://purl.obolibrary.org/obo/GO_0007049) (cell cycle), [GO:0007346](http://purl.obolibrary.org/obo/GO_0007346) (regulation of mitotic cell cycle), [GO:0005634](http://purl.obolibrary.org/obo/GO_0005634) (nucleus), [GO:0004702](http://purl.obolibrary.org/obo/GO_0004702) (signal transducer, downstream of receptor, with serine/threonine kinase activity), [GO:0005813](http://purl.obolibrary.org/obo/GO_0005813) (centrosome), [GO:0005856](http://purl.obolibrary.org/obo/GO_0005856) (cytoskeleton), [GO:0005737](http://purl.obolibrary.org/obo/GO_0005737) (cytoplasm), [GO:0046872](http://purl.obolibrary.org/obo/GO_0046872) (metal ion binding), [GO:2000001](http://purl.obolibrary.org/obo/GO_2000001) (regulation of DNA damage checkpoint), [GO:0016740](http://purl.obolibrary.org/obo/GO_0016740) (transferase activity), [GO:0016301](http://purl.obolibrary.org/obo/GO_0016301) (kinase activity), [GO:0071889](http://purl.obolibrary.org/obo/GO_0071889) (14-3-3 protein binding), 

**Class expressions from DL-Learner:**

- [GO:1904888](http://purl.obolibrary.org/obo/GO_1904888) (cranial skeletal system development) 58.33%
- [GO:0071889](http://purl.obolibrary.org/obo/GO_0071889) (14-3-3 protein binding) 58.33%
- [GO:0048232](http://purl.obolibrary.org/obo/GO_0048232) (male gamete generation) 58.33%
- [GO:0035264](http://purl.obolibrary.org/obo/GO_0035264) (multicellular organism growth) 58.33%
- [GO:0007283](http://purl.obolibrary.org/obo/GO_0007283) (spermatogenesis) 58.33%
- [GO:0005524](http://purl.obolibrary.org/obo/GO_0005524) (ATP binding) 58.33%
- [GO:0000242](http://purl.obolibrary.org/obo/GO_0000242) (pericentriolar material) 58.33%
- [GO:0032559](http://purl.obolibrary.org/obo/GO_0032559) (adenyl ribonucleotide binding) and [GO:0035639](http://purl.obolibrary.org/obo/GO_0035639) (purine ribonucleoside triphosphate binding) 58.33%
- [GO:0030554](http://purl.obolibrary.org/obo/GO_0030554) (adenyl nucleotide binding) and [GO:0035639](http://purl.obolibrary.org/obo/GO_0035639) (purine ribonucleoside triphosphate binding) 58.33%
- [GO:0008144](http://purl.obolibrary.org/obo/GO_0008144) (drug binding) and [GO:0035639](http://purl.obolibrary.org/obo/GO_0035639) (purine ribonucleoside triphosphate binding) 58.33%
- [GO:0030554](http://purl.obolibrary.org/obo/GO_0030554) (adenyl nucleotide binding) and [GO:0035639](http://purl.obolibrary.org/obo/GO_0035639) (purine ribonucleoside triphosphate binding) and [GO:0097367](http://purl.obolibrary.org/obo/GO_0097367) (carbohydrate derivative binding) 58.33%
- [GO:0030554](http://purl.obolibrary.org/obo/GO_0030554) (adenyl nucleotide binding) and [GO:0032555](http://purl.obolibrary.org/obo/GO_0032555) (purine ribonucleotide binding) and [GO:0035639](http://purl.obolibrary.org/obo/GO_0035639) (purine ribonucleoside triphosphate binding) 58.33%
- [GO:0030554](http://purl.obolibrary.org/obo/GO_0030554) (adenyl nucleotide binding) and [GO:0032553](http://purl.obolibrary.org/obo/GO_0032553) (ribonucleotide binding) and [GO:0035639](http://purl.obolibrary.org/obo/GO_0035639) (purine ribonucleoside triphosphate binding) 58.33%
- [GO:0008144](http://purl.obolibrary.org/obo/GO_0008144) (drug binding) and [GO:0035639](http://purl.obolibrary.org/obo/GO_0035639) (purine ribonucleoside triphosphate binding) and [GO:0097367](http://purl.obolibrary.org/obo/GO_0097367) (carbohydrate derivative binding) 58.33%
- [GO:0008144](http://purl.obolibrary.org/obo/GO_0008144) (drug binding) and [GO:0035639](http://purl.obolibrary.org/obo/GO_0035639) (purine ribonucleoside triphosphate binding) and [GO:0036094](http://purl.obolibrary.org/obo/GO_0036094) (small molecule binding) 58.33%


